Skip to main content
. 2016 Nov 3;5(1):1905. doi: 10.1186/s40064-016-3584-4

Table 3.

Functional outcome comparison

Variable RRP (N = 97) HDR (N = 161) Cryo (N = 114) HIFU (N = 120) P value
Urethral stricture, N (%) 29 (29.9) 10 (6.2) 4 (3.3) 13 (10.8) 0.000
Secondary TURP or OIU, N (%) 28 (28.9) 18 (11.2) 10 (8.8) 16 (13.3) 0.000
Urinary incontinence, N (%) 11 (11.3) 1 (0.6) 2 (1.6) 3 (2.5) 0.000
Epididymitis, N (%) 2 (2.1) 6 (3.7) 8 (7.3) 7 (5.8) 0.311
Scrotal edema, N (%) 0 (0.0) 0 (0.0) 85 (74.7) 0 (0.0) 0.000
Rectal injury, N (%) 1 (1.0) 3 (1.9) 0 (0.0) 0 (0.0) 0.243
Irradiation cystitis, N (%) 0 (0.0) 6 (3.7) 0 (0.0) 0 (0.0) 0.006
Irradiation proctitis, N (%) 0 (0.0) 7 (4.3) 0 (0.0) 0 (0.0) 0.002
Erectile dysfunction at 12 months, N (%)a 32/38 (84.2) 30/34 (88.2) 44/50 (88.0) 21/32 (65.6) 0.042
IIEF-5 at 6 months (mean ± SD)a 6.08 ± 6.27 4.85 ± 5.52 4.02 ± 5.95 8.55 ± 8.41 0.031
IIEF-5 at 12 months (mean ± SD)a 6.33 ± 6.06 4.81 ± 5.47 3.61 ± 5.21 9.67 ± 7.74 0.003
IIEF-5 at 18 months (mean ± SD)a 6.74 ± 6.07 4.79 ± 5.32 4.50 ± 5.96 10.16 ± 8.11 0.008
IIEF-5 at 24 months (mean ± SD)a 5.48 ± 5.28 4.76 ± 5.48 4.18 ± 5.89 9.36 ± 6.33 0.067
IPSS at 6 months (mean ± SD) 9.55 ± 6.11 7.51 ± 5.81 10.43 ± 6.50 7.26 ± 4.41 0.009
IPSS at 12 months (mean ± SD) 9.69 ± 6.01 7.48 ± 5.56 9.54 ± 5.87 6.25 ± 3.42 0.021
IPSS at 18 months (mean ± SD) 9.52 ± 6.05 7.49 ± 5.67 9.15 ± 6.08 5.82 ± 3.75 0.047
IPSS at 24 months (mean ± SD) 9.31 ± 5.83 7.50 ± 5.43 9.04 ± 6.30 5.70 ± 3.53 0.184
QoL at 6 months (mean ± SD) 2.50 ± 1.59 2.27 ± 1.33 2.75 ± 1.41 1.90 ± 0.14 0.017
QoL at 12 months (mean ± SD) 2.52 ± 1.57 2.30 ± 1.42 2.59 ± 1.42 1.83 ± 1.01 0.097
QoL at 18 months (mean ± SD) 2.45 ± 1.56 2.32 ± 1.28 2.5 ± 1.41 1.86 ± 1.17 0.318
QoL at 24 months (mean ± SD) 2.50 ± 1.65 2.33 ± 1.47 2.47 ± 1.40 1.98 ± 1.4 0.794

RRP radical retropubic prostatectomy, HDR high dose rate brachytherapy, Cryo cryoablation, HIFU high-intensity focused ultrasound, TURP transurethral resection of the prostate, OIU optic internal urethrotomy, SD standard deviation, IIEF-5 5-item version of the international index of erectile function, IPSS international prostate symptom score, QoL quality of life

aErectile dysfunction and Mean scores for IIEF-5 were restricted to those men who reported IIEF-5 ≥ 17 at baseline